Adalimumab in psoriatic arthritis: A viewpoint by Eric Ruderman

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate › peer-review

ASJC Scopus subject areas

@article{759b863d27df4bb7a99d8877d2fc0703,

title = "Adalimumab in psoriatic arthritis: A viewpoint by Eric Ruderman",

author = "Eric Ruderman",

year = "2006",

doi = "10.2165/00003495-200666110-00009",

language = "English (US)",

volume = "66",

pages = "1497",

journal = "Drugs",

issn = "0012-6667",

publisher = "Adis International Ltd",

number = "11",

}

TY - JOUR

T1 - Adalimumab in psoriatic arthritis

T2 - A viewpoint by Eric Ruderman

AU - Ruderman, Eric

PY - 2006

Y1 - 2006

UR - http://www.scopus.com/inward/record.url?scp=33747356717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747356717&partnerID=8YFLogxK

U2 - 10.2165/00003495-200666110-00009

DO - 10.2165/00003495-200666110-00009

M3 - Comment/debate

AN - SCOPUS:33747356717

SN - 0012-6667

VL - 66

SP - 1497

JO - Drugs

JF - Drugs

IS - 11

ER -